Tysabri, which should soon be available again, has run successful trials testing it against optic neuritis...
"Natalizumab Reduces Loss of Visual Function in Patients with Relapsing Multiple Sclerosis. This is a clever, focussed new study that shows Tysabri is effective in reducing visual damage due to Multiple Sclerosis.
"OBJECTIVE: To report data on the effects of natalizumab on loss of visual function in patients with relapsing multiple sclerosis (MS) in the AFFIRM and SENTINEL studies... CONCLUSIONS/RELEVANCE: Natalizumab reduces loss of visual function in patients with relapsing MS. Low-contrast letter acuity is a sensitive visual function outcome for MS trials."
Disclaimer: Any information you find on this site should not be considered medical advice. All decisions should be made with the consent of your doctor, otherwise you are at your own risk.